Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105244353 | 10524435 | 3 | F | 20160719 | 20141017 | 20160802 | EXP | US-JNJFOC-20141006128 | JANSSEN | THORNTON P. US SAFETY BRIEFS: FENTANYL PATCH FATALITIES LINKED TO BYSTANDER APATHY. WE ALL HAVE A ROLE IN PREVENTION. JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2013 2013;43(4):300-301. SMETZER J, COHEN MR, JENKINS R. FENTANYL PATCH FATALITIES LINKED TO BYSTANDER APATHY. WE ALL HAVE A ROLE IN PREVENTION!. ISMP MEDICATION SAFETY ALERT! SAFE MEDICINE CONSUMER EDITION. 2013;18:P.1-14. GRISSINGER M. FENTANYL PATCH FATALITIES: WE ALL HAVE A ROLE IN PREVENTION.. P + T 2016;41(7):405-6. | 0.00 | C | Y | 0.00000 | 20160802 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105244353 | 10524435 | 1 | PS | FENTANYL. | FENTANYL | 1 | Transdermal | N | 19813 | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
105244353 | 10524435 | 1 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
105244353 | 10524435 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
105244353 | 10524435 | Accidental exposure to product by child | |
105244353 | 10524435 | Overdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |